EarningsQ2 2021 Earnings Report

Altimmune (ALT1) Q2 2021 Earnings Report

0 Followers

MX:ALT1 Q2 2021 EPS Results

Actual EPS-$11.05

Consensus EPS-$9.30

Beat/MissMissed by -$1.75

One Year Ago EPS-$17.31

Actual Revenue$2.53M

Expected Revenue$34.84M

Beat/MissMissed by -$32.31M

YoY Revenue Growth-80.93%

QuarterQ2 2021

Date08/10/2021

TimeAfter Close

Conference CallTuesday, August 10, 2021

MX:ALT1 Upcoming Earnings

Altimmune's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 10, 2026	2026 (Q3)	-2.43 / -	-3.867	―
Aug 12, 2026	2026 (Q2)	-2.54 / -2.21	-4.972	55.56% (+2.76)
May 13, 2026	2026 (Q1)	-4.46 / -3.31	-4.788	30.77% (+1.47)
Mar 05, 2026	2025 (Q4)	-4.38 / -4.97	-6.077	18.18% (+1.10)
Nov 06, 2025	2025 (Q3)	-5.01 / -3.87	-5.893	34.38% (+2.03)
Aug 12, 2025	2025 (Q2)	-6.19 / -4.97	-6.445	22.86% (+1.47)
May 13, 2025	2025 (Q1)	-6.48 / -4.79	-6.261	23.53% (+1.47)
Feb 27, 2025	2024 (Q4)	-6.11 / -6.08	-9.944	38.89% (+3.87)
Nov 12, 2024	2024 (Q3)	-6.57 / -5.89	-7.182	17.95% (+1.29)
Aug 08, 2024	2024 (Q2)	-6.43 / -6.44	-5.893	-9.37% (-0.55)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed